{"title":"Side effects of vaccination against COVID-19: description of a case of isolated oculomotor nerve damage with a literature review","authors":"R. Gaifutdinov, Dinara Sh. Kamalova","doi":"10.17816/nb100332","DOIUrl":null,"url":null,"abstract":"In the era of the COVID-19 pandemic, unprecedented efforts have been made by governments and the scientific community to develop vaccines. Vaccines developed on the basis of new technologies have proven to be effective and safe. The accumulated experience in vaccine development on the basis of human adenovirus DNA has allowed domestic scientists to develop and launch the worlds first vaccine against a new coronavirus infection, Sputnik V, in a short period of time, which has received worldwide recognition. Pre-registration trials may be insufficient to detect rare post-vaccination complications, and the lack of information about them may cause distrust in vaccination companies among part of the population. A review of the worldwide literature on SARS-CoV-2 vaccine-related complications is presented. It concludes that vaccination is superior to their risks. An oculomotor nerve injury following vaccination with Sputnik Lite in a 67-year-old woman with a favourable outcome is described.","PeriodicalId":436189,"journal":{"name":"Neurology Bulletin","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/nb100332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In the era of the COVID-19 pandemic, unprecedented efforts have been made by governments and the scientific community to develop vaccines. Vaccines developed on the basis of new technologies have proven to be effective and safe. The accumulated experience in vaccine development on the basis of human adenovirus DNA has allowed domestic scientists to develop and launch the worlds first vaccine against a new coronavirus infection, Sputnik V, in a short period of time, which has received worldwide recognition. Pre-registration trials may be insufficient to detect rare post-vaccination complications, and the lack of information about them may cause distrust in vaccination companies among part of the population. A review of the worldwide literature on SARS-CoV-2 vaccine-related complications is presented. It concludes that vaccination is superior to their risks. An oculomotor nerve injury following vaccination with Sputnik Lite in a 67-year-old woman with a favourable outcome is described.